Antibodies to human B7x for treatment of metastatic cancer
US12221489B2 · kind B2 · utility
0Cited by
5References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2020 |
| Grant date | Feb 11, 2025 |
| Priority date | — |
| Expiry date | Jul 20, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided for treating metastatic cancer in patients having metastatic cancer or for preventing metastasis in cancer patients at risk for metastasis comprising administering to the patient an antibody to B7x, or an active antibody fragment that binds B7x, in an amount effective to treat or prevent metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.